Bright Minds Biosciences (DRUG) Skyrockets with Private Placement Announcement

Author's Avatar
3 days ago

Bright Minds Biosciences (DRUG, Financial) has seen its stock price surge dramatically, rising 52 times over the past five trading days and setting a new all-time high. Recently, the stock soared over 165%, reaching $57.72.

The surge follows the company's announcement of a private placement of common shares at $21.70 each. This non-brokered private placement also includes the issuance of prepaid company warrants (PFWs) priced at $21.699 each. The total gross proceeds from these offerings amount to $35 million.

The company retains the discretion over the number of shares and PFWs to be issued. The stock offering and the warrant issuance together comprise the financing package.

Disclosures

I/We may personally own shares in some of the companies mentioned above. However, those positions are not material to either the company or to my/our portfolios.